Less Severe Lipopolysaccharide-Induced Inflammation in Conditional mgmt-Deleted Mice with LysM-Cre System: The Loss of DNA Repair in Macrophages

Int J Mol Sci. 2023 Jun 14;24(12):10139. doi: 10.3390/ijms241210139.

Abstract

Despite the known influence of DNA methylation from lipopolysaccharide (LPS) activation, data on the O6-methylguanine-DNA methyltransferase (MGMT, a DNA suicide repair enzyme) in macrophages is still lacking. The transcriptomic profiling of epigenetic enzymes from wild-type macrophages after single and double LPS stimulation, representing acute inflammation and LPS tolerance, respectively, was performed. Small interfering RNA (siRNA) silencing of mgmt in the macrophage cell line (RAW264.7) and mgmt null (mgmtflox/flox; LysM-Crecre/-) macrophages demonstrated lower secretion of TNF-α and IL-6 and lower expression of pro-inflammatory genes (iNOS and IL-1β) compared with the control. Macrophage injury after a single LPS dose and LPS tolerance was demonstrated by reduced cell viability and increased oxidative stress (dihydroethidium) compared with the activated macrophages from littermate control mice (mgmtflox/flox; LysM-Cre-/-). Additionally, a single LPS dose and LPS tolerance also caused mitochondrial toxicity, as indicated by reduced maximal respiratory capacity (extracellular flux analysis) in the macrophages of both mgmt null and control mice. However, LPS upregulated mgmt only in LPS-tolerant macrophages but not after the single LPS stimulation. In mice, the mgmt null group demonstrated lower serum TNF-α, IL-6, and IL-10 than control mice after either single or double LPS stimulation. Suppressed cytokine production resulting from an absence of mgmt in macrophages caused less severe LPS-induced inflammation but might worsen LPS tolerance.

Keywords: epigenetics; lipopolysaccharide; macrophages; mgmt; sepsis.

MeSH terms

  • Animals
  • DNA / metabolism
  • DNA Repair / genetics
  • Inflammation / chemically induced
  • Inflammation / genetics
  • Inflammation / metabolism
  • Interleukin-6 / metabolism
  • Lipopolysaccharides* / pharmacology
  • Macrophages / metabolism
  • Mice
  • Tumor Necrosis Factor-alpha* / metabolism

Substances

  • Lipopolysaccharides
  • Tumor Necrosis Factor-alpha
  • Interleukin-6
  • Cre recombinase
  • DNA